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Abstract
Beta-Poisson (BP) models employ Poisson distributions, where the corre-
sponding rate parameter itself is a Beta-distributed random variable. They
have been shown to appropriately mimic gene expression distributions in
the context of single-cell ribonucleic acid sequencing (scRNA-seq), a break-
through technology allowing to sequence information from individual biologi-
cal cells and facilitating fundamental insights into numerous fields of biology.
A prominent scRNA-seq data analysis task is to identify differences in gene
expression distributions across two conditions. To validate new statistical ap-
proaches in this context, one typically has to rely on accurate simulations, as
usually no ground truth for an assessment is available. We introduce several
simulation procedures that allow to generate differential distributions (DDs)
based on BP models. In particular, we describe how to create different types
of DDs, mirroring various sources or origins of a difference, and different
degrees of DDs, from a weak to a strong difference. The soundness of the
simulation procedures is shown in a validation study in which theoretically
expected model properties of the DD simulations are confirmed. The findings
are in principle not restricted to the scRNA-seq context and may be gener-
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ally applicable also to other application areas. The simulation approaches
are implemented in the publicly available R package SimBPDD.
Keywords: Beta-Poisson model, differential distributions, single-cell RNA se-
quencing, Wasserstein distance
AMS Subject Classification: 62P10, 62-04, 62-08, 92-08
1. Introduction
Beta-Poisson (BP) models, sometimes also referred to as Poisson-Beta models,
employ Poisson distributions, where the corresponding rate parameter itself is a
Beta-distributed random variable [3, 4]. Thus, the BP distribution is an example of
a mixed Poisson distribution [6] and a discrete compound distribution, respectively.
It is used in various theoretical and practical applications [8, 13, 15, 17].
Specifically, the BP distribution has been recently used in the biological context
to model single-cell ribonucleic acid sequencing (scRNA-seq) data [15, 17]. Due
to major technological advances, it is nowadays possible to sequence information
from individual biological cells. Such single-cell sequencing, and in particular the
scRNA-seq, enables the quantification of cellular heterogeneity and provides new
fundamental insights into various biological fields [16], thus being highly relevant.
Along with the ever increasing amount of produced scRNA-seq data, there is a need
to develop statistical methods for the analysis of such data [1]. The most striking
difference compared to previous data obtained by bulk experiments is that gene
expression in scRNA-seq data is available over multiple cells and not only as an
average single point value. Consequently, models for scRNA-seq gene expression
should take the form of distributions. Moreover, they should take account of the
specific nature of scRNA-seq data (e.g. abundance of zero expression or increased
variability). Besides other approaches, the BP distribution considered in this paper
has been shown to model scRNA-seq data appropriately, where there are different
procedures for model fitting and estimation of model parameters [2, 15].
To evaluate novel statistical methods in scRNA-seq data analysis, simulations
play a very important role, as typically no ground truth is available for real data.
For instance, to adequately test and validate differential expression methods for
scRNA-seq data [2], it is important to simulate differential distributions (DDs) in
a reliable way. While there are already methods to do so [18], we here explicitly
focus on a specific procedure to generate DDs in the scRNA-seq context using BP
models. In particular, we describe how to create different types of DDs, mirroring
various sources or origins of a difference, and different degrees of DDs, from a weak
to a strong difference.
While the focus of this paper is on using BP models in the context of scRNA-seq
data, the generation of DDs for the BP models is generally applicable also to other
application areas, for both theoretical and practical considerations.
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2. Beta-Poisson models in scRNA-seq data
We here consider Beta-Poisson (BP) models as introduced in [15], which have been
found to appropriately mimic scRNA-seq data. Precisely, in [15], three different
BP models are considered: a three-parameter BP model (BP3), a four-parameter
BP model (BP4) and a five-parameter BP model (BP5).
The BP3 model is a mixture of Poisson distributions Poi(𝜆1𝑢) with mean 𝜆1𝑢,
where 𝜆1 ∈ (0,∞) denotes a scaling parameter and 𝑢 ∼ Beta(𝛼, 𝛽) has a Beta
distribution with parameters 𝛼 ∈ (0,∞) and 𝛽 ∈ (0,∞):
𝑋 ∼ BP3(𝑥|𝛼, 𝛽, 𝜆1) := Poi(𝑥|𝜆1 Beta(𝛼, 𝛽)).
Here, 𝛼 is a shape parameter, where a large 𝛼 indicates a high burst frequency
(i.e. transcription rate, where transcription bursts correspond to an “on” state),
and 𝛽 is a scale parameter, with a large 𝛽 indicating a high burst size [15, 17]. We
can interpret this in the way that 𝛼 may reflect among others the number of zero
expression values (i.e. the proportion of zero expression), while 𝛽 may mirror the
size or magnitude of the non-zero expression values.










(𝛼+ 𝛽)2(𝛼+ 𝛽 + 1)
,
respectively.
As the BP3 model can only account for count data (i.e. non-negative integers),
the BP4 model is proposed in [15], which employs an additional parameter 𝜆2 ∈
(0,∞) to allow for modeling non-negative real-valued data, i.e., the usual data
format we have to deal with after normalization of the raw scRNA-seq count data:
𝑌 ∼ BP4(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2) := 𝜆2 BP3(𝑥|𝛼, 𝛽, 𝜆1).
In addition to what has been done in [15], straightforward calculations yield











(𝛼+ 𝛽)2(𝛼+ 𝛽 + 1)
)︂
.
Finally, the BP5 model has an additional parameter 𝑝0 ∈ [0, 1] explicitly capturing
the proportion of cells with zero expression (besides the parameter 𝛼 reflecting the
burst frequency, as discussed before):
𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) := 𝑝01{𝑥=0} + (1− 𝑝0) BP4(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2)1{𝑥>0},
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with 1 denoting the indicator function. In addition to what has been outlined
in [15], by applying corresponding formulas for mixture distributions, it can be
computed that




Var(𝑍) = (1− 𝑝0)(E(𝑌 )2 + Var(𝑌 ))− E(𝑍)2.
Note that for 𝜆2 := 1 and 𝑝0 := 0, the BP4 and the BP5 models actually reduce to
the BP3 model.
3. Simulating differential distributions for Beta-
Poisson models
The starting point of our procedure is a pre-processed (including quality control and
normalization) real-experiment scRNA-seq data set in form of a (𝐺×𝐶) expression
matrix, with 𝐺 denoting the number of genes and 𝐶 the number of cells. We first
fit a BP5 model to the expression data for each gene separately using the method
provided by [15] in the R [12] package BPSC and obtain corresponding parameter
estimates 𝛼, 𝛽, 𝜆1, 𝜆2 and 𝑝0. Further, we test for each gene whether its distribution
is indeed fitted well by the corresponding BP5 model, using the procedure proposed
in Section 3.2 in [15]. While filtering out low-quality fits, the cases (genes) that
show a good fit, together with their corresponding parameter estimates, are kept
in our pipeline and will be referred to as the controls in what follows.
We then simulate differential distributions (DDs) for each control 𝑍 separately
by manipulating the corresponding parameters 𝛼, 𝛽 and 𝜆1. We do not explicitly
consider a manipulation of the parameter 𝜆2 here, as 𝜆2 only controls the transfor-
mation from (a discrete spectrum of) non-negative integers (expression counts) to
(a discrete spectrum of) non-negative real values (expression after normalization).
Moreover, we do not consider a manipulation of the parameter 𝑝0 at this point;
however, this will be discussed at the end of the section, when we explicitly describe
how to construct differential proportions of zero expression (DPZ) in the context
of BP5 models.
Here, we consider multiplicative manipulations of the parameters 𝛼, 𝛽 and 𝜆1
as follows, where we set 𝜆 := 𝜆1 for simplicity (as 𝜆2 is anyway not explicitly
considered): 𝜆 ↦→ ∆𝜆𝜆, 𝛼 ↦→ ∆𝛼𝛼, 𝛽 ↦→ ∆𝛽𝛽. The parameters obtained by (one or
multiple of) these transformations are then the corresponding parameters in the
manipulated BP5 model 𝑍. As 𝜆 ∈ (0,∞), 𝛼 ∈ (0,∞) and 𝛽 ∈ (0,∞), it must hold
that ∆𝜆 ∈ (0,∞), ∆𝛼 ∈ (0,∞) and ∆𝛽 ∈ (0,∞), respectively, to get a reasonable
model.
We not only want to create DDs, but also to incorporate different degrees 𝜃 of
DD that range from weak to strong differences. Here, a degree 𝜃 of DD between a
control BP5 model 𝑍 and a manipulated BP5 model 𝑍 is first introduced using a
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multiplicative change (i.e., a fold change) with respect to the expected value:
E(𝑍) = 𝜃E(𝑍).
Inserting the corresponding expressions for the expected values and some algebra
yields




Hence, 𝜃 = 𝜃(∆𝜆,∆𝛼,∆𝛽) can be viewed as a function of ∆𝜆,∆𝛼 and ∆𝛽 , and the
degree of DD can be specified by varying ∆𝜆,∆𝛼 and ∆𝛽 , respectively. Vice versa,
we may consider ∆𝜆 as a function of 𝜃 in case ∆𝛼 and ∆𝛽 are fixed, i.e., ∆𝜆 = ∆𝜆(𝜃).
Analogously, ∆𝛼 = ∆𝛼(𝜃) in case ∆𝜆 and ∆𝛽 are fixed, and ∆𝛽 = ∆𝛽(𝜃) in case
∆𝜆 and ∆𝛼 are fixed. Note here again that 𝜃 generally refers to the degree of the
DD (weak to strong), while ∆𝜆,∆𝛼 or ∆𝛽 represents the model manipulation that
is necessary in order to achieve a DD of degree 𝜃.
To get an understanding of the influence of the single parameter manipulations
and to facilitate interpretability, we here first only consider those cases in which
only one of the three original BP5 model parameters is changed.
Case DLambda:
Here, the model is changed by manipulating the parameter 𝜆 only: 𝜆 ↦→ ∆𝜆𝜆, and
∆𝛼 = ∆𝛽 = 1.
By inserting the corresponding expressions in (3.1), we get
𝜃 = 𝜃(∆𝜆) = E(𝑍)/E(𝑍) = ∆𝜆,
i.e.,
∆𝜆 = ∆𝜆(𝜃) = 𝜃.
As 𝜃(0) = 0 and 𝜃(∆𝜆) → ∞ for ∆𝜆 → ∞, 𝜃 is bounded from below by zero, but
has no upper bound. Hence, the range for possible values of 𝜃 is 𝜃 ∈ (0,∞). DDs
of arbitrary degree can be created using either positively oriented or negatively
oriented fold changes. Here, a negatively oriented fold change means that E(𝑍) <
E(𝑍), hence, 𝜃 ∈ (0, 1). Conversely, a positively oriented fold change means that
E(𝑍) > E(𝑍), hence, 𝜃 ∈ (1,∞). For instance, a positively oriented fold change of
3 in our setting here practically has the same effect as a negatively oriented fold
change of 1/3, as we are only interested in the magnitude (i.e. the degree) of the
difference here, and not in the direction of the change.
A manipulation of the scaling parameter 𝜆 in the BP model, while keeping
Beta(𝛼, 𝛽) unmodified, changes location (mean) and size (variance). In contrast,
the shape should be affected only to a minor extent by a manipulation as here, if
at all [15, 17]. Moreover, a change of 𝜆 should not affect the proportion of zero
expression too much.
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Case DAlpha:
Here, the model is changed by manipulating the parameter 𝛼 only: 𝛼 ↦→ ∆𝛼𝛼, and
∆𝜆 = ∆𝛽 = 1.
By inserting the corresponding expressions in (3.1), we get





∆𝛼 = ∆𝛼(𝜃) =
𝛽𝜃
(𝛼+ 𝛽)− 𝛼𝜃 .
As 𝜃(0) = 0 and limΔ𝛼→∞ 𝜃(∆𝛼) = 1+
𝛽
𝛼 , 𝜃 is bounded from below by zero and has
an upper bound 1 + 𝛽𝛼 . Hence, the range for possible values of 𝜃 is 𝜃 ∈ (0, 1 +
𝛽
𝛼 ).
DDs can be generated using positively oriented (i.e. 𝜃 ∈ (1, 1 + 𝛽𝛼 )) or negatively
oriented (i.e. 𝜃 ∈ (0, 1)) fold changes. However, DDs of arbitrary degree can thus
be created using negatively oriented fold changes only.
Here, location, size and shape can change. Also, a manipulation of 𝛼 can affect
the proportion of zero expression.
Case DBeta:
Here, the model is changed by manipulating the parameter 𝛽 only: 𝛽 ↦→ ∆𝛽𝛽, and
∆𝜆 = ∆𝛼 = 1.
By inserting the corresponding expressions in (3.1), we get









As 𝜃(0) = 1+ 𝛽𝛼 and limΔ𝛽→∞ 𝜃(∆𝛽) = 0, 𝜃 is bounded from below by zero and has
an upper bound 1 + 𝛽𝛼 . Hence, the range for possible values of 𝜃 is 𝜃 ∈ (0, 1 +
𝛽
𝛼 ).
DDs can be generated using positively oriented (i.e. 𝜃 ∈ (1, 1 + 𝛽𝛼 )) or negatively
oriented (i.e. 𝜃 ∈ (0, 1)) fold changes. However, DDs of arbitrary degree can thus
be created using negatively oriented fold changes only.
Here, location, size and shape can change. However, a manipulation of 𝛽 should
in principle not affect the proportion of zero expression too much.
We now consider a specific scenario, in which the expected value of the control
BP5 model is the same as that of the manipulated BP5 model. The construction of
such a type of DD may be relevant in case one wants to check whether an scRNA-
seq differential expression analysis method is able to detect differences that are not
caused by differences with respect to means [7].
288 R. Schefzik
Case DAlphaBeta:
Here, the model is changed by manipulating both the parameters 𝛼 and 𝛽 using a
common parameter ∆ := ∆𝛼 = ∆𝛽 : 𝛼 ↦→ ∆𝛼, 𝛽 ↦→ ∆𝛽, and ∆𝜆 = 1.
As 𝛼, 𝛽 ∈ (0,∞), it must hold that ∆ ∈ (0,∞) to get a reasonable model. As
discussed before, the expected value of the manipulated model 𝑍 in this setting is
the same as the expected value of the control model 𝑍: E(𝑍) = E(𝑍). We therefore
introduce DDs by considering a multiplicative manipulation (i.e., a fold change) 𝜃 of
the variance instead of the expected value, with somewhat more complex formulas
involved:
Var(𝑍) = 𝜃 Var(𝑍).
Thus,
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i.e., after some tedious calculations,





































































































[E(𝑍)(E(𝑌 ) + 𝜆2 − E(𝑍))] .
Hence, the range for possible values of 𝜃 is 𝜃 ∈ (𝐿low, 𝐿up), where 0 < 𝐿low < 1 <
𝐿up. It is therefore not possible to create arbitrary degrees of DD in each case, be
it for positively or negatively oriented fold changes with respect to the variance.
Note again that here, only size and shape change, but not the location. However,
also the proportion of zero expression can change, as 𝛼 varies, even though a
variation of 𝛽 should have no effect on this.
Finally, we consider the construction of manipulated BP5 models with an ex-
plicit difference with respect to the proportion of zero expression, compared to the
control model.
Table 1. Settings for the DD simulations based on BP models,
where 5 corresponds to “no” and Xto “yes”.





























DLambda 𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) vs. 𝑍 ∼ BP5(𝑥|𝛼, 𝛽,∆𝜆𝜆1, 𝜆2, 𝑝0) 𝜆1 5 5 X
DAlpha 𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) vs. 𝑍 ∼ BP5(𝑥|∆𝛼𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) 𝛼 5 5 5
DBeta 𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) vs. 𝑍 ∼ BP5(𝑥|𝛼,∆𝛽𝛽, 𝜆1, 𝜆2, 𝑝0) 𝛽 5 5 5
DAlphaBeta 𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) vs. 𝑍 ∼ BP5(𝑥|∆𝛼,∆𝛽, 𝜆1, 𝜆2, 𝑝0) 𝛼, 𝛽 X 5 5
DPZ 𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0) vs. 𝑍 ∼ BP5(𝑥|𝛼, 𝛽, 𝜆1, 𝜆2, 𝑝0 + ∆𝑝0) 𝑝0 5 5 5
Case DPZ:
Here, the model is changed by manipulating the parameter 𝑝0 of the control BP5
model only: 𝑝0 ↦→ 𝑝0 := 𝑝0 + ∆𝑝0 , leading to differential proportions of zero
expression (DPZ). While there is no intuitive feeling for the parameter ranges of the
parameters 𝜆, 𝛼 and 𝛽, which is the reason why we used the models described above
to construct different degrees of DDs for the other cases, we have an immediate
and clear interpretability of the parameter 𝑝0.
As it has to hold that 𝑝0 + ∆𝑝0 ∈ [0, 1] (since 𝑝0 ∈ [0, 1]), we choose ∆𝑝0 as follows:
∆𝑝0 =
{︃
𝜃, 𝜃 ≤ 1− 𝑝0,
−𝜃, 𝜃 < 𝑝0,
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where 𝜃 ∈ (0, 0.5]. A change of 𝑝0 should obviously affect the proportion of zero
expression.
For an overview of all the considered settings described before, which are partly
similar to those in [14], see the summaries in Tables 1 and 2. For the cases
DLambda, DAlpha and DBeta, it is recommended to only consider negatively ori-
ented fold changes 𝜃 (i.e. 𝜃 ∈ (0, 1)), as all possible degrees of DDs can be achieved
only using them. For the case DAlphaBeta, all possible degrees of DDs indeed can-
not be achieved with negatively oriented fold changes, but neither this works for
positively oriented fold changes. Hence, for reasons of consistency, we by default
also focus on negatively oriented fold changes then.
Table 2. General overview of the different manipulated models
𝑍 of the control BP5 models 𝑍. Note that for the case DAl-













. Here, Δ may refer
to Δ𝜆,Δ𝛼,Δ𝛽 or Δ𝑝0 , according to the descriptions of the corre-
sponding cases in the main text.
case manipulation choice of ∆ possible values for 𝜃
DLambda E(𝑍) = 𝜃E(𝑍) ∆ = 𝜃 𝜃 ∈ (0,∞)
DAlpha E(𝑍) = 𝜃E(𝑍) ∆ = 𝛽𝜃(𝛼+𝛽)−𝛼𝜃 𝜃 ∈ (0, 1 +
𝛽
𝛼 )
DBeta E(𝑍) = 𝜃E(𝑍) ∆ = (𝛼+𝛽)−𝛼𝜃𝛽𝜃 𝜃 ∈ (0, 1 +
𝛽
𝛼 )









DPZ 𝑝0 = 𝑝0 + ∆ ∆ =
{︂
𝜃, 𝜃 ≤ 1− 𝑝0
−𝜃, 𝜃 < 𝑝0 𝜃 ∈ (0, 0.5]
4. Validation study
4.1. Evaluation tools
To validate the soundness of our simulation procedures, we employ the waddR tool
available at https://github.com/goncalves-lab/waddR. Specifically, a semi-
parametric, permutation-based test using the 2-Wasserstein distance is applied to
compare two distributions 𝐹𝐴 and 𝐹𝐵 [10].
In our validation study, for each instance (here, each gene), information about
𝐹𝐴 (the control model) and 𝐹𝐵 (the manipulated model) is available in the form
of a sample 𝑥𝐴,1, . . . , 𝑥𝐴,𝐶𝐴 from 𝐹𝐴, and 𝑥𝐵,1, . . . , 𝑥𝐵,𝐶𝐵 from 𝐹𝐵 , respectively,
where in general, 𝐶𝐴 does not need to equal 𝐶𝐵 . In the context of scRNA-seq
data, the sample sizes 𝐶𝐴 and 𝐶𝐵 correspond to the respective numbers of cells.
Using the corresponding empirical cumulative distribution functions 𝐹𝐴 and 𝐹𝐵 as
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≈ (?̂?𝐴 − ?̂?𝐵)2⏟  ⏞  
location
+ (?̂?𝐴 − ?̂?𝐵)2⏟  ⏞  
size
+ 2?̂?𝐴?̂?𝐵(1− 𝜌𝐴,𝐵)⏟  ⏞  
shape⏟  ⏞  
variability
, (4.1)
with (𝑄𝛼𝑘𝐴 )𝑘=1,...,𝐾 and (𝑄
𝛼𝑘
𝐵 )𝑘=1,...,𝐾 denoting the 𝛼𝑘-quantiles of 𝐹𝐴 and 𝐹𝐵 ,
respectively, where we use equidistant levels 𝛼𝑘 = 𝑘−0.5𝐾 , 𝑘 = 1, . . . ,𝐾. Here,
?̂?𝐴, ?̂?𝐵 denote the corresponding empirical means, ?̂?𝐴, ?̂?𝐵 the corresponding em-
pirical standard deviations, and
𝜌𝐴,𝐵 := Cor((𝑄
𝛼1




𝐵 , . . . , 𝑄
𝛼𝐾
𝐵 ))
the sample Pearson correlation coefficient between (𝑄𝛼𝑘𝐴 )𝑘=1,...,𝐾 and (𝑄
𝛼𝑘
𝐵 )𝑘=1,...,𝐾 .
For the calculations, we use 𝐾 := 1000 here.
For each instance separately, we calculate the corresponding 2-Wasserstein dis-
tance as a test statistic and obtain a p-value using a semi-parametric, permutation-
based testing procedure involving a generalized Pareto distribution approximation
to estimate very small p-values accurately. Along with the p-value, the decom-
position of the 2-Wasserstein distance in (4.1) may help to judge whether overall
differences between two distributions (i.e. BP models) are mainly due to differences
with respect to location (referring to differences with respect to the expected val-
ues), size (referring to differences with respect to the standard deviations) and/or
shape (referring to differences not mainly caused by differences with respect to
expected values and/or standard deviations) [5, 9].
To explicitly test for DPZ, we use Fisher’s exact test, applied to each instance
separately.
4.2. Setting
In the following validation study, we start with the real-experiment scRNA-seq
data set in [11], downloaded from https://hemberg-lab.github.io/scRNA.seq.
datasets/human/tissues. The data set consists of log2-transformed TPM (tran-
scripts per million) expression values, normalized for both gene length and sequenc-
ing depth, for 301 cells, where we only keep those genes from the original data set
that are expressed in at least three cells. A BP5 model is fitted to each gene in the
data set using the R package BPSC [15]. Specifically, maximum likelihood estima-
tion combined with a binning approach to reduce computation time is employed to
estimate the model parameters, using the standard R function optim for optimiza-
tion. For more details, in particular the choice of initial values for the BP model
optimization, see Section 3 in [15]. To assess the quality of the BP5 model fits,
a goodness-of-fit test statistic comparing the observed and expected frequencies
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from the model is considered, where a Monte-Carlo method is used to generate a
suitable null distribution that is employed to derive a corresponding p-value 𝑃 . A
gene is then declared to be fitted well by the BP model if 𝑃 ≥ 0.05. For details,
see Section 3.2 in [15]. In our study, 8773 genes are declared to be fitted well by
the corresponding BP5 model. For the further analyses, we keep only these well-
fitted genes as controls, from which manipulated BP5 models are then constructed
according to the procedures discussed before. At this point, we emphasize that for
our purposes here, the real data set in [11] is only used for obtaining reasonable BP
model parameters in the scRNA-seq context, from which the control and manipu-
lated BP models in our purely numerical experiments are constructed. However, no
specific biological investigations or aspects are considered in our validation study.
For each case (see Tables 1 and 2), we here consider five different degrees 𝜃
of DD, ranging from weak to strong, where the explicit choices for 𝜃 are shown
in Table 3. Note that for the cases DLambda, DAlpha, DBeta and DPZ, these
degrees of DD can be achieved for all 8773 genes in the simulation study, and all
these genes are used in the studies. In contrast, for the case DAlphaBeta, due to
the existence of the lower bound 𝐿low, we only keep those genes for the study for
which the corresponding degree of DD can be achieved.
As representatives of the corresponding control and manipulated BP5 models,
for each gene, we draw a sample from each model. In this context, the samples from
a BP distribution are independent random draws. Specifically, the function rBP
from the BPSC package is used for drawing the samples from the BP distributions,
which combines the classical rpois and rbeta functions for randomly drawing from
Poisson and Beta distributions, respectively, in R. In our study, we for convenience
consider situations in which the sample size (i.e. the number of cells) 𝐶 := 𝐶𝐴 = 𝐶𝐵
in both conditions (control and manipulated) is equal and cover a range 𝐶 ∈
{25, 50, 75, 100, 500} of examples for small to large sample sizes.
Table 3. Different degrees of DDs specifically chosen in the
simulation study.
case
degree D1 D2 D3 D4 D5
DLambda, DAlpha, DBeta, DAlphaBeta 𝜃 = 10/11 𝜃 = 2/3 𝜃 = 1/2 𝜃 = 2/5 𝜃 = 1/3
DPZ 𝜃 = 0.05 𝜃 = 0.1 𝜃 = 0.25 𝜃 = 0.4 𝜃 = 0.5
weak strong
4.3. Results
We now discuss the results for the validation study in terms of detection power and
the decomposition of the 2-Wasserstein distance in the waddR test. In this context,
for each fixed case, degree of DD and number of cells, detection power is defined
as
detection power =
# p-values ≤ 𝛼
# tests (genes)
,
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Table 4. Detection powers (in %), based on p-values at a 5%
significance level, with varying degrees of DD (D1: weak to D5:
strong), numbers of cells 𝐶 ∈ {25, 50, 75, 100, 500} and cases from
Table 1.
case
degree D1 D2 D3 D4 D5
DLambda waddR DD 1.39 8.48 21.86 32.06 38.31
Fisher DPZ 0.25 0.40 0.48 1.03 1.87
DAlpha waddR DD 1.57 7.67 18.03 26.73 32.73
Fisher DPZ 0.30 1.45 5.11 10.48 16.95
DBeta waddR DD 1.61 8.36 20.43 30.42 36.24





DAlphaBeta waddR DD 1.35 2.50 5.50 0.87 12.66
Fisher DPZ 0.20 1.64 7.55 16.53 25.67
DPZ waddR DD 1.37 2.09 23.50 54.21 65.61
Fisher DPZ 0.26 0.39 12.71 68.97 77.03
DLambda waddR DD 2.17 17.91 40.61 51.61 58.00
Fisher DPZ 0.40 0.52 1.58 3.21 5.49
DAlpha waddR DD 2.14 14.89 34.22 44.88 50.95
Fisher DPZ 0.59 3.65 14.97 29.02 38.32
DBeta waddR DD 2.47 16.77 37.25 48.93 55.08





DAlphaBeta waddR DD 1.62 4.09 10.92 19.49 23.96
Fisher DPZ 0.51 4.29 19.48 37.09 53.11
DPZ waddR DD 1.99 6.62 50.83 75.56 81.33
Fisher DPZ 0.57 1.30 67.11 82.75 86.11
DLambda waddR DD 2.83 27.62 53.06 63.75 69.63
Fisher DPZ 0.54 0.97 2.58 5.04 8.36
DAlpha waddR DD 2.72 22.61 44.74 56.35 62.93
Fisher DPZ 0.68 6.38 26.38 42.00 51.76
DBeta waddR DD 2.36 25.35 49.29 60.31 67.05





DAlphaBeta waddR DD 1.83 6.01 18.10 26.30 32.86
Fisher DPZ 0.83 7.54 33.13 56.49 70.34
DPZ waddR DD 2.62 12.19 66.05 81.98 84.94
Fisher DPZ 0.81 7.61 79.41 86.78 88.93
DLambda waddR DD 3.00 34.41 60.21 71.21 76.56
Fisher DPZ 0.51 0.95 3.08 6.84 11.23
DAlpha waddR DD 2.90 28.78 52.10 63.48 69.96
Fisher DPZ 0.88 9.80 34.42 50.88 60.58
DBeta waddR DD 3.05 31.63 56.41 67.54 74.75






DAlphaBeta waddR DD 1.62 9.05 26.51 35.93 40.39
Fisher DPZ 0.98 11.42 45.10 69.32 81.52
DPZ waddR DD 3.64 17.85 74.09 83.98 86.91
Fisher DPZ 1.09 15.76 83.11 88.62 90.74
DLambda waddR DD 11.67 76.78 93.35 96.82 97.61
Fisher DPZ 0.81 5.30 15.05 30.35 46.37
DAlpha waddR DD 9.86 68.94 87.43 92.57 94.85
Fisher DPZ 2.68 53.03 78.10 88.13 92.83
DBeta waddR DD 10.40 72.12 90.07 94.94 96.90






DAlphaBeta waddR DD 3.04 62.78 78.12 85.17 89.33
Fisher DPZ 2.87 59.94 92.03 96.65 98.57
DPZ waddR DD 23.74 70.61 87.99 91.51 93.25


































































































































































































































































































































































































































































































Figure 1: Decomposition results for the waddR test for the xed number of cells C = 25, based on averages
over those of the runs that are considered to show signicant DDs in that the corresponding p-value is less than
or equal to 0.05, with cases according to Table ??.
1
Figure 1. Decomposition results for the waddR test for varying
degrees of DD (D1: weak to D5: strong) and numbers of cells 𝐶 ∈
{25, 50, 75, 100, 500}, based on averages over those of the runs that
are considered to show significant DDs in that the corresponding
p-value is ≤ 0.05, with cases according to Table 1.
with 𝛼 ∈ (0, 1). Detection powers for the different numbers of cells for the stan-
dard level of 𝛼 = 5% are listed in Table 4. In general, for all cases, detection
powers meaningfully increase with increasing numbers of cells. Moreover, they in-
crease with increasing strength of the difference between the distributions (weak
to strong degree of DD; D1 to D5). While only very little detection power can be
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observed for the very weak degree of DD D1, the detection powers get bigger for the
stronger degrees of DD, for which the differences become more and more obvious.
This intuitively makes sense and confirms in particular that the implementation
of the varying degrees of DD from weak to strong in our simulation procedure
is valid. When comparing the p-values of the waddR test and the separate DPZ
test, we observe that DPZ can mainly be detected when the parameters 𝛼 or 𝑝0
are changed (i.e. in the cases DAlpha, DAlphaBeta and DPZ). In contrast, DPZ
typically plays only a minor role when the parameters 𝜆 or 𝛽 are changed (i.e. in
the cases DLambda and DBeta). This is in line with the theoretical properties and
the interpretation of the parameters of the BP model.
A further confirmation that the simulation procedures are able to reflect what
is to be expected from the underlying theory (Table 1) of the BP model is given
by the decomposition of the 2-Wasserstein distance into location, size and shape
parts within the waddR test. For the different degrees of DDs and numbers of
cells, Figure 1 shows for all cases the average fractions of the location, size and
shape parts with respect to the overall 2-Wasserstein distance for the waddR test
based on those runs with a p-value less than or equal to 5%. Again, the respective
decomposition patterns meaningfully become more and more obvious the larger the
number of cells is and the stronger the degree of DD is. In particular, the shape
and location component in the cases DLambda and DAlphaBeta, respectively, are
minor to negligible compared to the corresponding other components, in line with
the theoretical models according to Table 1. Moreover, for instance, the shape
component is more pronounced in cases in which the shape parameter 𝛼 is changed
(i.e. in the cases DAlpha and DAlphaBeta) than in those where 𝛼 is not changed
(i.e. in the cases DLambda and DBeta). An explicit change of the proportion of
zero expression by manipulating the parameter 𝑝0 (case DPZ) can obviously also
affect the shape.
5. Discussion
We have discussed how to create DDs of varying degrees, ranging from weak to
strong differences, for BP models, using various manipulations of the BP model
parameters. The soundness of our approaches has been shown in a validation study,
in which theoretically expected properties of our procedures have been confirmed.
In particular, based on the construction of our simulations and their validation
in the study, we can provide some guidance on how to generate DDs between two
BP models when the difference shall be of a specific type. For instance, when no
difference with respect to shape is desired, the DLambda simulation, in which only
the BP model parameter 𝜆 is changed, can be used. Similarly, in case no difference
with respect to location is desired, one can employ the DAlphaBeta simulation, in
which the BP model parameters 𝛼 and 𝛽 are changed using a common manipulation
parameter. In case there shall be no DPZ, one may rely on the DLambda or DBeta
simulations, in which only the BP model parameters 𝜆 and 𝛽, respectively, are
changed.
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Despite the focus of this paper is on the application field of scRNA-seq data, the
introduced procedures can in principle be applied also to settings in other research
areas.
While we have presented first attempts to simulate DDs for BP models here, we
by far did not consider all possible combinations of BP parameter manipulations.
This provides opportunities for future work, in which in particular interactions
of changes when multiple BP parameters are manipulated simultaneously could be
investigated in more detail. Moreover, up to now, only univariate BP distributions,
that allow for individual (gene-wise) modeling, have been considered in the models
here. However, certain variables may be correlated (such as genes in the scRNA-
seq context), and taking account of specific correlation structures is an important
issue that could be addressed in future extensions of the models.
Software availability. The simulations of DDs based on BP models presented in
this paper are implemented in the R package SimBPDD, which is publicly available
at https://github.com/RomanSchefzik/SimBPDD, along with documentation of
the functions.
Acknowledgements. Angela Goncalves and Marc Schwering are thanked for
helpful discussions and useful comments. Moreover, thanks are given to two anony-
mous reviewers for valuable comments and suggestions. The work was funded by
project VH-NG-1010 of the HGF.
References
[1] R. Bacher, C. Kendziorski: Design and computational analysis of single-cell RNA-sequen-
cing experiments, Genome Biology 17 (2016), art. 63,
doi: https://doi.org/10.1186/s13059-016-0927-y.
[2] M. Delmans, M. Hemberg: Discrete distributional differential expression (D3E) – a tool
for gene expression analysis of single-cell RNA-seq data, BMC Bioinformatics 17 (2016),
art. 110,
doi: https://doi.org/10.1186/s12859-016-0944-6.
[3] J. Gurland: A generalized class of contagious distributions, Biometrics 14 (1958), pp. 229–
249,
doi: https://doi.org/10.2307/2527787.
[4] M. S. Holla, S. K. Bhattacharya: On a discrete compound distribution, Annals of the
Institute of Statistical Mathematics 17 (1965), pp. 377–384,
doi: https://doi.org/10.1007/BF02868181.
[5] A. Irpino, R. Verde: Basic statistics for distributional symbolic variables: a new metric-
based approach, Advances in Data Analysis and Classification 9 (2015), pp. 143–175,
doi: https://doi.org/10.1007/s11634-014-0176-4.
[6] D. Karlis, E. Xekalaki: Mixed Poisson distributions, International Statistical Review 73
(2005), pp. 35–58.
[7] K. D. Korthauer, L.-F. Chu, M. A. Newton, Y. Li, J. Thomson, R. Stewart, C.
Kendziorski: A statistical approach for identifying differential distributions in single-cell
RNA-seq experiments, Genome Biology 17 (2016), art. 222,
doi: https://doi.org/10.1186/s13059-016-1077-y.
SimBPDD: Simulating differential distributions in Beta-Poisson models, . . . 297
[8] K. L. Leask, L. M. Haines: The beta-Poisson distribution in Wadley’s problem, Commu-
nications in Statistics–Theory and Methods 43 (2014), pp. 4962–4971,
doi: https://doi.org/10.1080/03610926.2012.744047.
[9] Y. Matsui, M. Mizuta, S. Ito, S. Miyano, T. Shimamura: D3M: detection of differential
distributions of methylation levels, Bioinformatics 32 (2016), pp. 2248–2255,
doi: https://doi.org/10.1093/bioinformatics/btw138.
[10] V. M. Panaretos, Y. Zemel: Statistical aspects of Wasserstein distances, Annual Review
of Statistics and Its Application 6 (2019), pp. 405–431,
doi: https://doi.org/10.1146/annurev-statistics-030718-104938.
[11] A. A. Pollen, T. J. Nowakowski, J. Shuga, X. Wang, A. A. Leyrat, J. H. Lui, N. Li,
L. Szpankowski, B. Fowler, P. Chen, N. Ramalingam, G. Sun, M. Thu, M. Norris, R.
Lebofsky, D. Toppani, D. W. Kemp II, M. Wong, B. Clerkson, B. N. Jones, S. Wu,
L. Knutsson, B. Alvarado, J. Wang, L. S. Weaver, A. P. May, R. C. Jones, M. A.
Unger, A. R. Kriegstein, J. A. A. West: Low-coverage single-cell mRNA sequencing
reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex,
Nature Biotechnology 32 (2014), pp. 1053–1058,
doi: https://doi.org/10.1038/nbt.2967.
[12] R Core Team: R: A Language and Environment for Statistical Computing, R Foundation
for Statistical Computing, Vienna, Austria, 2020,
url: https://www.R-project.org/.
[13] J. M. Sarabia, E. Gómez-Déniz: Multivariate Poisson-Beta distributions with applica-
tions, Communications in Statistics–Theory and Methods 40 (2011), pp. 1093–1108,
doi: https://doi.org/10.1080/03610920903537269.
[14] M. Schwering: Batch effects in single cell RNA sequencing analysis, MA thesis, Heidelberg
University, 2017.
[15] T. N. Vu, Q. F. Wills, K. R. Kalari, N. Niu, L. Wang, M. Rantalainen, Y. Paw-
itan: Beta-Poisson model for single-cell RNA seq data analyses, Bioinformatics 32 (2016),
pp. 2128–2135,
doi: https://doi.org/10.1093/bioinformatics/btw202.
[16] Y. Wang, N. E. Nevin: Advances and applications of single-cell sequencing technologies,
Molecular Cell 58 (2015), pp. 598–609,
doi: https://doi.org/10.1016/j.molcel.2015.05.005.
[17] Q. F. Wills, K. J. Livak, A. J. Tipping, T. Enver, A. J. Goldson, D. W. Sexton, C.
Holmes: Single-cell gene expression analysis reveals genetic associations masked in whole-
tissue experiments, Nature Biotechnology 31 (2013), pp. 748–752,
doi: https://doi.org/10.1038/nbt.2642.
[18] L. Zappia, B. Phipson, A. Oshlack: Splatter: simulation of single-cell RNA sequencing
data, Genome Biology 18 (2017), art. 174,
doi: https://doi.org/10.1186/s13059-017-1305-0.
298 R. Schefzik
